Unique Thermodynamic Response of Tipranavir to Human Immunodeficiency Virus Type 1 Protease Drug Resistance Mutations

Drug resistance is a major problem affecting the clinical efficacy of antiretroviral agents, including protease inhibitors, in the treatment of infection with human immunodeficiency virus type 1 (HIV-1)/AIDS. Consequently, the elucidation of the mechanisms by which HIV-1 protease inhibitors maintain...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Muzammil, S., Armstrong, A. A., Kang, L. W., Jakalian, A., Bonneau, P. R., Schmelmer, V., Amzel, L. M., Freire, E.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2007
Sujets:
Vaccines and Antiviral Agents
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC1900215/
https://ncbi.nlm.nih.gov/pubmed/17360759
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.02706-06
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires